Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'TACHYKININ NK1 RECEPTOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 120 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Harrison, S; Geppetti, P
      Substance P

      INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
    2. May, A; Goadsby, PJ
      Substance P receptor antagonists in the therapy of migraine

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    3. May, A; Goadsby, PJ
      Pharmacological opportunities and pitfalls in the therapy of migraine

      CURRENT OPINION IN NEUROLOGY
    4. Millet, R; Goossens, L; Goossens, JF; Chavatte, P; Bertrand-Caumont, K; Houssin, R; Henichart, JP
      Conformation of the tripeptide Cbz-Pro-Leu-Trp-OBzl(CF3)(2) deduced from two-dimensional H-1-NMR and conformational energy calculations is related toits affinity for NK1-receptor

      JOURNAL OF PEPTIDE SCIENCE
    5. Cocquyt, V; Van Belie, S; Reinhardt, RR; Decramer, MLA; O'Brien, M; Schellens, JHM; Borms, M; Verbeke, L; Van Aelst, F; De Smet, M; Carides, AD; Eldridge, K; Gertz, BJ
      Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis

      EUROPEAN JOURNAL OF CANCER
    6. Hokfelt, T; Pernow, B; Wahren, J
      Substance P: a pioneer amongst neuropeptides

      JOURNAL OF INTERNAL MEDICINE
    7. Gurrath, M
      Peptide-binding G protein-coupled receptors: New opportunities for drug design

      CURRENT MEDICINAL CHEMISTRY
    8. Campos, D; Pereira, JR; Reinhardt, RR; Carracedo, C; Poli, S; Vogel, C; Martinez-Cedillo, J; Erazo, A; Wittreich, J; Eriksson, LO; Carides, AD; Gertz, BJ
      Prevention of cisplatin-induced emesis by the oral neurokinin-1 antagonist, MK-869, in combination with granisetron and dexamethasone or with dexamethasone alone

      JOURNAL OF CLINICAL ONCOLOGY
    9. Stout, SC; Owens, MJ; Nemeroff, CB
      Neurokinin(1) receptor antagonists as potential antidepressants

      ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
    10. Shrikhande, SV; Friess, H; di Mola, FF; Tempia-Caliera, A; Garcia, JRC; Zhu, ZW; Zimmermann, A; Buchler, MW
      NK-1 receptor gene expression is related to pain in chronic pancreatitis

      PAIN
    11. Jocic, M; Schuligoi, R; Schoninkle, E; Pabst, MA; Holzer, P
      Cooperation of NMDA and tachykinin NK1 and NK2 receptors in the medullary transmission of vagal afferent input from the acid-threatened rat stomach

      PAIN
    12. Andrews, PLR; Kovacs, M; Watson, JW
      The anti-emetic action of the neurokinin(1) receptor antagonist CP-99,994 does not require the presence of the area postrema in the dog

      NEUROSCIENCE LETTERS
    13. Trafton, JA; Abbadie, C; Basbaum, AI
      Differential contribution of substance P and neurokinin a to spinal cord neurokinin-1 receptor signaling in the rat

      JOURNAL OF NEUROSCIENCE
    14. Mancuso, F; Porta, R; Calignano, A; Di Pierro, P; Sommella, MG; Esposito, C
      Substance P and its transglutaminase-synthesized spermine derivative elicit yawning behavior via nitric oxide in rats

      PEPTIDES
    15. Santarelli, L; Gobbi, G; Debs, PC; Sibille, EL; Blier, P; Hen, R; Heath, MJS
      Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    16. Costa, SKP; Esquisatto, LCM; Camargo, E; Gambero, A; Brain, SD; De Nucci, G; Antunes, E
      Comparative effect of Phoneutria nigriventer spider venom and capsaicin onthe rat paw oedema

      LIFE SCIENCES
    17. Kamp, EH; Beck, DR; Gebhart, GF
      Combinations of neurokinin receptor antagonists reduce visceral hyperalgesia

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    18. Smith, BJ; Doran, AC; McLean, S; Tingly, FD; O'Neill, BT; Kajiji, SM
      P-glycoprotein efflux at the blood-brain barrier mediates differences in brain disposition and pharmacodynamics between two structurally related neurokinin-1 receptor antagonists

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    19. Okano, S; Nagaya, H; Ikeura, Y; Natsugari, H; Inatomi, N
      Effects of TAK-637, a novel neurokinin-1 receptor antagonist, on colonic function in vivo

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    20. Millan, MJ; Lejeune, F; De Nanteuil, G; Gobert, A
      Selective blockade of neurokinin (NK)(1) receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in rats

      JOURNAL OF NEUROCHEMISTRY
    21. Vruwink, M; Schmidt, HHHW; Weinberg, RJ; Burette, A
      Substance P and nitric oxide signaling in cerebral cortex: Anatomical evidence for reciprocal signaling between two classes of interneurons

      JOURNAL OF COMPARATIVE NEUROLOGY
    22. Pellegrini, M; Bremer, AA; Ulfers, AL; Boyd, ND; Mierke, DF
      Molecular characterization of the substance P center dot neurokinin-1 receptor complex - Development of an experimentally based model

      JOURNAL OF BIOLOGICAL CHEMISTRY
    23. Saeki, M; Sakai, M; Saito, R; Kubota, H; Ariumi, H; Takano, Y; Yamatodani, A; Kamiya, H
      Effects of HSP-117, a novel tachykinin NK1-receptor antagonist, on cisplatin-induced pica as a new evaluation of delayed emesis in rats

      JAPANESE JOURNAL OF PHARMACOLOGY
    24. Kamo, I; Doi, T
      Effect of TAK-637, a tachykinin NK1-Receptor antagonist, on lower urinary tract function in cats

      JAPANESE JOURNAL OF PHARMACOLOGY
    25. Minami, M; Endo, T; Yokota, H; Ogawa, T; Nemoto, M; Hamaue, N; Hirafuji, M; Yoshioka, M; Nagahisa, A; Andrews, PLR
      Effects of CP-99, 994, a tachykinin NK1 receptor antagonist, on abdominal afferent vagal activity in ferrets: evidence for involvement of NK1 and 5-HT3 receptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    26. Bremer, AA; Tansky, MF; Wu, MY; Boyd, ND; Leeman, SE
      Direct evidence for the interaction of neurokinin A with the tachykinin NK1 receptor in tissue

      EUROPEAN JOURNAL OF PHARMACOLOGY
    27. Ballard, TM; Sanger, S; Higgins, GA
      Inhibition of shock-induced foot tapping behaviour in the gerbil by a tachykinin NK1 receptor antagonist

      EUROPEAN JOURNAL OF PHARMACOLOGY
    28. Joshi, DD; Dang, AJ; Yadav, P; Qian, J; Bandari, PS; Chen, KH; Donnelly, R; Castro, T; Gascon, P; Haider, A; Rameshwar, P
      Negative feedback on the effects of stem cell factor on hematopoiesis is partly mediated through neutral endopeptidase activity on substance P: a combined functional and proteomic study

      BLOOD
    29. Argyropoulos, SV; Nutt, DJ
      Substance P antagonists: novel agents in the treatment of depression

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    30. Leroy, V; Mauser, P; Gao, ZL; Peet, NP
      Neurokinin receptor antagonists

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    31. Shahbazian, A; Holzer, P
      Differences in circular muscle contraction and peristaltic motor inhibition caused by tachykinin NK1 receptor agonists in the guinea-pig small intestine

      NEUROGASTROENTEROLOGY AND MOTILITY
    32. Haddjeri, N; Blier, P
      Effect of neurokinin-I receptor antagonists on the function of 5-HT and noradrenaline neurons

      NEUROREPORT
    33. Davis, MP; Walsh, D
      Treatment of nausea and vomiting in advanced cancer

      SUPPORTIVE CARE IN CANCER
    34. Cable, KM; Wells, GN; Sutherland, DR
      Synthesis of carbon-14 labelled NK-1 receptor antagonists GR203040 and GR205171

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    35. Vassout, A; Veenstra, S; Hauser, K; Ofner, S; Brugger, F; Schilling, W; Gentsch, C
      NKP608: a selective NK-1 receptor antagonist with anxiolytic-like effects in the social interaction and social exploration test in rats

      REGULATORY PEPTIDES
    36. Hood, VC; Cruwys, SC; Urban, L; Kidd, BL
      Differential role of neurokinin receptors in human lymphocyte and monocytechemotaxis

      REGULATORY PEPTIDES
    37. Hasenohrl, RU; De Souza-Silva, MA; Nikolaus, S; Tomaz, C; Brandao, ML; Schwarting, RKW; Huston, JP
      Substance P and its role in neural mechanisms governing learning, anxiety and functional recovery

      NEUROPEPTIDES
    38. Bergstrom, M; Fasth, KJ; Kilpatrick, G; Ward, P; Cable, KM; Wipperman, MD; Sutherland, DR; Langstrom, B
      Brain uptake and receptor binding of two [C-11]labelled selective high affinity NK1-antagonists, GR203040 and GR205171 - PET studies in rhesus monkey

      NEUROPHARMACOLOGY
    39. Palma, C; Maggi, CA
      The role of tachykinins via NK1 receptors in progression of human gliomas

      LIFE SCIENCES
    40. Pedersen, KE; Buckner, CK; Meeker, SN; Undem, BJ
      Pharmacological examination of the neurokinin-1 receptor mediating relaxation of human intralobar pulmonary artery

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    41. Vedani, A; Briem, K; Dobler, M; Dollinger, H; McMasters, DR
      Multiple-conformation and protonation-state representation in 4D-QSAR: Theneurokinin-1 receptor system

      JOURNAL OF MEDICINAL CHEMISTRY
    42. Liu, J; Underwood, DJ; Cascieri, MA; Rohrer, SP; Cantin, LD; Chicchi, G; Smith, AB; Hirschmann, R
      Synthesis of a substance P antagonist with a somatostatin scaffold: Factors affecting agonism/antagonism at GPCRs and the role of pseudosymmetry

      JOURNAL OF MEDICINAL CHEMISTRY
    43. Widner, C; Klede, M; Rukwied, R; Lischetzki, G; Neisius, U; Skov, PS; Petersen, LJ; Schmelz, M
      Acute effects of substance P and calcitonin gene-related peptide in human skin - A microdialysis study

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    44. Kamo, I; Imai, S; Okanishi, S; Doi, T
      Possible site of action of TAK-637, a tachykinin NK1 receptor antagonist, on the micturition reflex in guinea pigs

      EUROPEAN JOURNAL OF PHARMACOLOGY
    45. Campbell, VA; Beddy, P; Foley, A; Bakhle, YS; Bell, C
      Reduced inflammation in genetically hypertensive rat airways is associatedwith reduced tachykinin NK1 receptor numbers

      EUROPEAN JOURNAL OF PHARMACOLOGY
    46. Linardi, A; Costa, SKP; da Silva, GR; Antunes, E
      Involvement of kinins, mast cells and sensory neurons in the plasma exudation and paw oedema induced by staphylococcal enterotoxin B in the mouse

      EUROPEAN JOURNAL OF PHARMACOLOGY
    47. Doi, T; Kamo, I; Imai, S; Okanishi, S; Ikeura, Y; Natsugari, H
      Effects of TAK-637, a tachykinin receptor antagonist, on the micturition reflex in guinea pigs

      EUROPEAN JOURNAL OF PHARMACOLOGY
    48. Lin, YS; Kou, YR
      Acute neurogenic airway plasma exudation and edema induced by inhaled woodsmoke in guinea pigs: role of tachykinins and hydroxyl radical

      EUROPEAN JOURNAL OF PHARMACOLOGY
    49. Costa, SKP; De Nucci, G; Antunes, E; Brain, SD
      Involvement of vanilloid receptors and purinoceptors in the Phoneutria nigriventer spider venom-induced plasma extravasation in rat skin

      EUROPEAN JOURNAL OF PHARMACOLOGY
    50. Lecci, A; Giuliani, S; Tramontana, M; Meini, S; Santicioli, P; Maggi, CA
      Tachykinin-mediated effect of nociceptin in the rat urinary bladder in vivo

      EUROPEAN JOURNAL OF PHARMACOLOGY
    51. Palma, C; Bigioni, M; Irrissuto, C; Nardelli, F; Maggi, CA; Manzini, S
      Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograft

      BRITISH JOURNAL OF CANCER
    52. Gao, ZL; Peet, NP
      Recent advances in neurokinin receptor antagonists

      CURRENT MEDICINAL CHEMISTRY
    53. Andrews, PLR
      Cyclic vomiting syndrome - Timing, targets, and treatment - A basic science perspective

      DIGESTIVE DISEASES AND SCIENCES
    54. Huskey, SEW; Luffer-Atlas, D; Dean, BJ; McGowan, EM; Feeney, WP; Chiu, SHL
      Substance P receptor antagonist I: Conversion of phosphoramidate prodrug after i.v. administration to rats and dogs

      DRUG METABOLISM AND DISPOSITION
    55. Navari, RM; Reinhardt, RR; Gralla, RJ; Kris, MG; Hesketh, PJ; Khojasteh, A; Kindler, H; Grote, TH; Pendergrass, K; Grunberg, SM; Carides, AD; Gertz, BJ
      Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptorantagonist

      NEW ENGLAND JOURNAL OF MEDICINE
    56. Barchasz, E; Naline, E; Molimard, M; Moreau, J; Georges, O; Emonds-Alt, X; Advenier, C
      Interleukin-1 beta-induced hyperresponsiveness to [Sar(9),Met(O-2)(11)]substance P in isolated human bronchi

      EUROPEAN JOURNAL OF PHARMACOLOGY
    57. Matos, IM; Souza, DG; Seabra, DG; Freire-Maia, L; Teixeira, MM
      Effects of tachykinin NK1 or PAF receptor blockade on the lung injury induced by scorpion venom in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    58. Saria, A
      The tachykinin NK1 receptor in the brain: pharmacology and putative functions

      EUROPEAN JOURNAL OF PHARMACOLOGY
    59. Palma, C; Nardelli, F; Manzini, S
      Correlation between binding characteristics and functional antagonism in human glioma cells by tachykinin NK1 receptor antagonists

      EUROPEAN JOURNAL OF PHARMACOLOGY
    60. Cutrufo, C; Evangelista, S; Cirillo, R; Ciucci, A; Conte, B; Lopez, G; Manzini, S; Maggi, CA
      Effect of MEN 11467, a new tachykinin NK1 receptor antagonist, in acute rectocolitis induced by acetic acid in guinea-pigs

      EUROPEAN JOURNAL OF PHARMACOLOGY
    61. Ogawa, K; Nabe, T; Yamamura, H; Kohno, S
      Nanomolar concentrations of neuropeptides induce histamine release from peritoneal mast cells of a substrain of Wistar rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    62. Nikolaus, S; Huston, JP; Hasenohrl, RU
      Reinforcing effects of neurokinin substance P in the ventral pallidum: mediation by the tachykinin NK1 receptor

      EUROPEAN JOURNAL OF PHARMACOLOGY
    63. Matos, IM; Teixeira, MM; Leite, R; Freire-Maia, L
      Pharmacological evidence that neuropeptides mediate part of the actions ofscorpion venom on the guinea pig ileum

      EUROPEAN JOURNAL OF PHARMACOLOGY
    64. Rudd, JA; Ngan, MP; Wai, MK
      Inhibition of emesis by tachykinin NK1 receptor antagonists in Suncus murinus (house musk shrew)

      EUROPEAN JOURNAL OF PHARMACOLOGY
    65. Romerio, SC; Linder, L; Haefeli, WE
      Neurokinin-1 receptor antagonist R116301 inhibits substance P-induced venodilation

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    66. van Houwelingen, AH; van der Avoort, LA; van Heuven-Nolsen, D; Kraneveld, AD; Nijkamp, FP
      Repeated challenge with dinitrobenzene sulphonic acid in dinitrofluorobenzene-sensitized mice results in vascular hyperpermeability in the trachea: arole for tachykinins

      BRITISH JOURNAL OF PHARMACOLOGY
    67. Cellier, E; Barbot, L; Iyengar, S; Couture, R
      Characterization of central and peripheral effects of septide with the useof five tachykinin NK1 receptor antagonists in the rat

      BRITISH JOURNAL OF PHARMACOLOGY
    68. Palma, C; Nardelli, F; Manzini, S; Maggi, CA
      Substance P activates responses correlated with tumour growth in human glioma cell lines bearing tachykinin NK1 receptors

      BRITISH JOURNAL OF CANCER
    69. Rose, JB; Watcha, MF
      Postoperative nausea and vomiting in paediatric patients

      BRITISH JOURNAL OF ANAESTHESIA
    70. Sakurada, C; Sakurada, S; Katsuyama, S; Sasaki, J; Tan-No, K; Sakurada, T
      Involvement of tachykinin NK1 receptors in nociceptin-induced hyperalgesiain mice

      BRAIN RESEARCH
    71. Fukuda, H; Nakamura, E; Koga, T; Furukawa, N; Shiroshita, Y
      The site of the anti-emetic action of tachykinin NK1 receptor antagonists may exist in the medullary area adjacent to the semicompact part of the nucleus ambiguus

      BRAIN RESEARCH
    72. HERRSTEDT J
      ANTIEMETIC RESEARCH - A LOOK TO THE FUTURE

      Supportive care in cancer
    73. KRAMER MS; CUTLER N; FEIGHNER J; SHRIVASTAVA R; CARMAN J; SRAMEK JJ; REINES SA; LIU GH; SNAVELY D; WYATTKNOWLES E; HALE JJ; MILLS SG; MACCOSS M; SWAIN CJ; HARRISON T; HILL RG; HEFTI F; SCOLNICK EM; CASCIERI MA; CHICCHI GG; SADOWSKI S; WILLIAMS AR; HEWSON L; SMITH D; CARLSON EJ; HARGREAVES RJ; RUPNIAK NMJ
      DISTINCT MECHANISM FOR ANTIDEPRESSANT ACTIVITY BY BLOCKADE OF CENTRALSUBSTANCE-P RECEPTORS

      Science
    74. HALE JJ; MILLS SG; MACCOSS M; FINKE PE; CASCIERI MA; SADOWSKI S; BER E; CHICCHI GG; KURTZ M; METZGER J; EIERMANN G; TSOU NN; TATTERSALL FD; RUPNIAK NMJ; WILLIAMS AR; RYCROFT W; HARGREAVES R; MACINTYRE DE
      STRUCTURAL OPTIMIZATION AFFORDING ENYL-4-(3-OXO-1,2,4-TRIAZOL-5-YL)METHYLMORPHOLINE, A POTENT, ORALLY-ACTIVE, LONG-ACTING MORPHOLINE ACETALHUMAN NK-1 RECEPTOR ANTAGONIST

      Journal of medicinal chemistry
    75. Rudd, JA; Cheng, CHK; Naylor, RJ
      Serotonin-independent model of cisplatin-induced emesis in the ferret

      JAPANESE JOURNAL OF PHARMACOLOGY
    76. MCALLISTER KHM; PRATT JA
      GR205171 BLOCKS APOMORPHINE AND AMPHETAMINE-INDUCED CONDITIONED TASTE-AVERSIONS

      European journal of pharmacology
    77. CORBOZ MR; RIVELLI MA; RAMOS SI; RIZZO CA; HEY JA
      TACHYKININ NK1 RECEPTOR-MEDIATED VASORELAXATION IN HUMAN PULMONARY-ARTERIES

      European journal of pharmacology
    78. HAHN MK; BANNON MJ
      TACHYKININ NK1 RECEPTOR ANTAGONISTS ENHANCE STRESS-INDUCED C-FOS IN RAT LOCUS-COERULEUS

      European journal of pharmacology
    79. WESTRADEVLIEGER JF; VANDENWIJNGAARD PWJ; KOSTER AS; WILTING J; LEYSEN J; VANHEUVENNOLSEN D; NIJKAMP FP
      THE TACHYKININ NK1 RECEPTOR ANTAGONIST, RP67580, INHIBITS THE BRADYKININ-INDUCED RISE IN INTRACELLULAR CA2-ARTERY ENDOTHELIAL-CELLS( CONCENTRATION IN BOVINE PULMONARY)

      European journal of pharmacology
    80. CIRILLO R; ASTOLFI M; CONTE B; LOPEZ G; PARLANI M; TERRACCIANO R; FINCHAM CI; MANZINI S
      PHARMACOLOGY OF THE PEPTIDOMIMETIC, MEN-11149, A NEW POTENT, SELECTIVE AND ORALLY EFFECTIVE TACHYKININ NK1 RECEPTOR ANTAGONIST

      European journal of pharmacology
    81. Goldhill, J; Angel, I
      Mechanism of tachykinin NK3 receptor-mediated colonic ion transport in theguinea pig

      EUROPEAN JOURNAL OF PHARMACOLOGY
    82. Minami, M; Endo, T; Kikuchi, K; Ihira, E; Hirafuji, M; Hamaue, N; Monma, Y; Sakurada, T; Tan-No, K; Kisara, K
      Antiemetic effects of sendide, a peptide tachykinin NK1 receptor antagonist, in the ferret

      EUROPEAN JOURNAL OF PHARMACOLOGY
    83. COSTA SKP; DENUCCI G; ANTUNES E; BRAIN SD
      PHONEUTRIA NIGRIVENTER SPIDER VENOM INDUCES EDEMA IN RAT SKIN BY ACTIVATION OF CAPSAICIN-SENSITIVE SENSORY NERVES

      European journal of pharmacology
    84. JOOS GF; LEFEBVRE RA; BULLOCK GR; PAUWELS RA
      ROLE OF 5-HYDROXYTRYPTAMINE AND MAST-CELLS IN THE TACHYKININ-INDUCED CONTRACTION OF RAT TRACHEA IN-VITRO

      European journal of pharmacology
    85. LUNDSTROM K; HAWCOCK AB; VARGAS A; WARD P; THOMAS P; NAYLOR A
      EFFECT OF SINGLE-POINT MUTATIONS OF THE HUMAN TACHYKININ NK1 RECEPTORON ANTAGONIST AFFINITY

      European journal of pharmacology
    86. RUPNIAK NMJ; TATTERSALL FD; WILLIAMS AR; RYCROFT W; CARLSON EJ; CASCIERI MA; SADOWSKI S; BER E; HALE JJ; MILLS SG; MACCOSS M; SEWARD E; HUSCROFT I; OWEN S; SWAIN CJ; HILL RG; HARGREAVES RJ
      IN-VITRO AND IN-VIVO PREDICTORS OF THE ANTIEMETIC ACTIVITY OF TACHYKININ NK1 RECEPTOR ANTAGONISTS

      European journal of pharmacology
    87. CASCIERI MA; BER E; FONG TM; HALE JJ; TANG F; SHIAO LL; MILLS SG; MACCOSS M; SADOWSKI S; TOTA MR; STRADER CD
      CHARACTERIZATION OF THE BINDING AND ACTIVITY OF A HIGH-AFFINITY, PSEUDOIRREVERSIBLE MORPHOLINO TACHYKININ NK1 RECEPTOR ANTAGONIST

      European journal of pharmacology
    88. RUPNIAK NMJ; CARLSON E; BOYCE S; WEBB JK; HILL RG
      ENANTIOSELECTIVE INHIBITION OF THE FORMALIN PAW LATE-PHASE BY THE NK1RECEPTOR ANTAGONIST L-733,060 IN GERBILS

      Pain
    89. ANDOH T; NAGASAWA T; KURAISHI Y
      EXPRESSION OF TACHYKININ NK1 RECEPTOR MESSENGER-RNA IN DORSAL-ROOT GANGLIA OF THE MOUSE

      Molecular brain research
    90. CELLIER E; FAYOLLE C; HIPSKIND PA; IYENGAR S; COUTURE R
      PERIPHERAL EFFECTS OF 3 NOVEL NONPEPTIDE TACHYKININ NK1 RECEPTOR ANTAGONISTS IN THE ANESTHETIZED RAT

      European journal of pharmacology
    91. KOBARI M; TOMITA M; TANAHASHI N; YOKOYAMA M; TAKAO M; FUKUUCHI Y
      INTRAVASCULAR SUBSTANCE-P DILATES CEREBRAL PARENCHYMAL VESSELS THROUGH A SPECIFIC TACHYKININ NK1 RECEPTOR IN CATS

      European journal of pharmacology
    92. SEABROOK GR; SHEPHEARD SL; WILLIAMSON DJ; TYRER P; RIGBY M; CASCIERI MA; HARRISON T; HARGREAVES RJ; HILL RG
      L-733,060, A NOVEL TACHYKININ NK1 RECEPTOR ANTAGONIST - EFFECTS IN [CA2+](I) MOBILIZATION, CARDIOVASCULAR AND DURAL EXTRAVASATION ASSAYS

      European journal of pharmacology
    93. TEIXEIRA RM; SANTOS ARS; RIBEIRO SJ; CALIXTO JB; RAE GA; DELIMA TCM
      EFFECTS OF CENTRAL ADMINISTRATION OF TACHYKININ RECEPTOR AGONISTS ANDANTAGONISTS ON PLUS-MAZE BEHAVIOR IN MICE

      European journal of pharmacology
    94. YASHPAL K; HUICHAN CWY; HENRY JL
      SR-48968 SPECIFICALLY DEPRESSES NEUROKININ-A-INDUCED VS SUBSTANCE-P-INDUCED HYPERALGESIA IN A NOCICEPTIVE WITHDRAWAL REFLEX

      European journal of pharmacology
    95. ANDREWS P; TORII Y; SAITO H; MATSUKI N
      THE PHARMACOLOGY OF THE EMETIC RESPONSE TO UPPER GASTROINTESTINAL-TRACT STIMULATION IN SUNCUS-MURINUS

      European journal of pharmacology
    96. GONSALVES S; WATSON J; ASHTON C
      BROAD-SPECTRUM ANTIEMETIC EFFECTS OF CP-122,721, A TACHYKININ NK1 RECEPTOR ANTAGONIST, IN FERRETS

      European journal of pharmacology
    97. PATACCHINI R; SANTICIOLI P; MAGGI CA
      EFFECT OF NIFLUMIC ACID ON ELECTROMECHANICAL COUPLING BY TACHYKININ NK1 RECEPTOR ACTIVATION IN RABBIT COLON

      European journal of pharmacology
    98. FIGINI M; EMANUELI C; BERTRAND C; JAVDAN P; GEPPETTI P
      EVIDENCE THAT TACHYKININS RELAX THE GUINEA-PIG TRACHEA VIA NITRIC-OXIDE RELEASE AND BY STIMULATION OF A SEPTIDE-INSENSITIVE NK1 RECEPTOR

      British Journal of Pharmacology
    99. REN K; IADAROLA MJ; DUBNER R
      AN ISOBOLOGRAPHIC ANALYSIS OF THE EFFECTS OF N-METHYL-D-ASPARTATE ANDNK1 TACHYKININ RECEPTOR ANTAGONISTS ON INFLAMMATORY HYPERALGESIA IN THE RAT

      British Journal of Pharmacology
    100. PISPISA B; CAVALIERI F; VENANZI M; SISTO A
      ABSORPTION, EMISSION, AND CHIROPTICAL SPECTRA OF NEUROKININ-1 TACHYKININ RECEPTOR ANTAGONISTS - THE ROLE OF CHARGE-TRANSFER STATES ON THE BIOLOGICAL-ACTIVITY

      Biopolymers


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 03:09:25